News

Glad ‘trashes’ excess plastic for more green product

BY Allison Cerra

NEW YORK — Glad wants consumers to waste less by making its tall kitchen trash bags more green.

Glad said that its tall kitchen bags are stronger and use less plastic, and will carry the claims on its packaging. The brand’s Glad tall kitchen bags and Glad OdorShield Fresh Scents tall kitchen drawstring bags utilize 6.5% less plastic, the company said. What’s more, Glad also touts a 65% recycled kitchen bag, made from 65% recycled plastic, as well as compostable bags that are made with approximately 40% vegetable-based materials so they disintegrate at compost facilities.

Glad products are available at retailers nationwide.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

P&G launches new oral care products to target garlic, onion breath

BY Antoinette Alexander

CINCINNATI — Procter & Gamble’s Scope hit the road this summer to encourage people to breathe easy after savoring the flavor of their favorite foods — especially onions and garlic. Appearing at food festivals across the country, Scope introduced its latest collection of products featuring new Dual-Blast technology, which helps eliminate strong food odors, such as onion and garlic, while killing bad breath germs.

The new offering includes Scope Dual-Blast mouthwash and Crest Complete Multi-Benefit Extra White + Scope Dual-Blast toothpaste.

This summer, Scope Dual-Blast was put to the ultimate torture test at food festivals around the country. Among the stops was the Gilroy Garlic Festival in Gilroy, Calif., which is otherwise known as the "Garlic Capital of the World." Festival-goers were able to visit the Scope Dual-Blast booth to freshen-up with new Scope Dual-Blast mouthwash and Crest Complete Multi-Benefit Extra White + Scope Dual-Blast toothpaste. In addition to the Gilroy Garlic Festival, Scope Dual-Blast toured the country through September stopping at 22 food festivals and football games.

Joining Dual-Blast in the bad breath crusade is Food Network’s Sunny Anderson, who combines her love of classic comfort foods along with unique, bold flavors inspired by her many travels around the world. Anderson partnered with Scope to show people that they can breathe easy even after enjoying her most flavorful dishes thanks to the new Dual-Blast technology.

"The new Scope Dual-Blast mouthwash and Crest Complete Multi-Benefit Extra White + Scope Dual-Blast toothpaste feature the unique dual-action technology that not only kills 98% of bad breath germs, but the rinse blasts away strong food odors and the toothpaste helps to eliminate strong aftertastes so they won’t be noticed," stated Veronica Sanchez, scientific communication for P&G Global Oral Care. "Our innovative Dual-Blast technology captures the odor-emitting volatile sulfur compounds (VSCs) from foods such as garlic and onions, helping to neutralize strong food odors in the mouth."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Takeda launches late-stage trial program for Type 2 diabetes drug

BY Alaric DeArment

OSAKA, Japan — Takeda Pharmaceuticals has started a late-stage clinical trial program for a drug to treat Type 2 diabetes, the drug maker said.

Takeda announced the start of the phase 3 trial of TAK-875 in the United States, Latin America and Europe. Previous studies have indicated that the drug, which belongs to a class known as GPR40 agonists, lowers glucose in patients’ blood by stimulating the secretion of glucose-dependent insulin in the pancreas. The first phase-3 trial in the program will enroll about 450 patients in the United States, Latin America and Europe.

"Takeda is committed to enhancing the clinical investigation of TAK-875 in order to accelerate the development of a potential new Type 2 diabetes treatment option for patients and healthcare professionals," Takeda Global Research and Development Center VP clinical science Thomas Strack said. "An outcome of our robust focus on diabetes over many years, TAK-875 was discovered by Takeda based on our GPRC research and is the first GPR40 agonist to reach late-stage clinical development."


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?